US FDA: Tainted compounded Avastin linked to serious eye infections, blindness
This article was originally published in Scrip
Executive Summary
The off-label ocular use of Genentech's Avastin (bevacizumab) has resulted in at least a dozen patients developing a serious eye infection, with some leading to blindness, following the intravitreal injection of a tainted compounded formulation of the drug that had been repackaged by a Florida pharmacy, US regulators said.